Does CLOTIAZEPAM Cause Hypovolaemia? 6 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hypovolaemia have been filed in association with CLOTIAZEPAM. This represents 1.9% of all adverse event reports for CLOTIAZEPAM.
6
Reports of Hypovolaemia with CLOTIAZEPAM
1.9%
of all CLOTIAZEPAM reports
0
Deaths
1
Hospitalizations
How Dangerous Is Hypovolaemia From CLOTIAZEPAM?
Of the 6 reports, 1 (16.7%) required hospitalization, and 5 (83.3%) were considered life-threatening.
Is Hypovolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOTIAZEPAM. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CLOTIAZEPAM Cause?
Coma (65)
Toxicity to various agents (54)
Somnolence (52)
Suicide attempt (31)
Fall (25)
Poisoning (24)
Confusional state (21)
Dizziness (19)
Hypotension (19)
Drug use disorder (17)
What Other Drugs Cause Hypovolaemia?
FUROSEMIDE (346)
METFORMIN (281)
EMPAGLIFLOZIN (150)
SPIRONOLACTONE (123)
DEXAMETHASONE (117)
HYDROCHLOROTHIAZIDE (94)
PREDNISONE (91)
LISINOPRIL (86)
METOPROLOL (84)
ACETAMINOPHEN (77)
Which CLOTIAZEPAM Alternatives Have Lower Hypovolaemia Risk?
CLOTIAZEPAM vs CLOTRIMAZOLE
CLOTIAZEPAM vs CLOXACILLIN
CLOTIAZEPAM vs CLOXAZOLAM
CLOTIAZEPAM vs CLOZAPINE
CLOTIAZEPAM vs CLOZARIL